Measurement of P-glycoprotein expression in human neuroblastoma xenografts using in vitro quantitative autoradiography (246 views visite)
Nucl Med Biol (ISSN: 0969-8051, 0883-2897), 1999 Jan; 26(1): 35-41.
Export to Esporta in BibTeX Export to Esporta in EndNote
Paper type Tipo di articolo: Journal Article,
Impact factor: 1.623, 5-year impact factor Impact factor a 5 anni: 2.442
Url: http://www.scopus.com/inward/record.url?eid=2-s2.0-0032891335&partnerID=40&md5=4f03b29e8e055cd92d87b0175450d18b
Keywords Parole chiave: Mrk16, Multidrug Resistance, P-Glycoprotein, Quantitative Autoradiography, Self-Competitive Binding Assay, Iodine 125, Monoclonal Antibody Mrk 16, Animal Experiment, Article, Cancer Cell Culture, Cancer Transplantation, Human, Human Cell, Isotope Labeling, Mouse, Neuroblastoma, Nonhuman, Nude Mouse, Protein Determination, Protein Expression, Quantitative Assay, Radioassay, Tissue Distribution, Antibodies, Multiple, Iodine Radioisotopes, Inbred Balb C, Neoplasm Transplantation, Heterologous, Tumor Cells,
Affiliations Affiliazioni:
Department of Nuclear Medicine, Mem. Sloan-Kettering Cancer C., New York, NY, United States
Inst. of Molec. and Cell. Biosci., University of Tokyo, Tokyo, Japan
References Riferimenti:
Aldrich, C.D., Pleiotropic phenothype of cultured murine cells resistant to maytansine, vincristine, colchicine and adriamycin (1979) J. Natl. Cancer Inst., 63, pp. 751-75
Beck, W.T., Grogan, T.M., Willman, C.L., Cordon-Cardo, C., Parham, D.M., Kuttesch, J.F., Andreeff, M., Weinstein, R., Methods to detect P-glycoprotein-associated multidrug resistance in patients' tumors: Consensus recommendations (1996) Cancer Res, 56, pp. 3010-3020
Biedler, J.L., Cassals, D., Chang, T.D., Meyers, M.B., Ross, R.A., Multidrug resistant human neuroblastoma cells are more differentiated than controls and retinoic acid further induces lineage-specific differentiation (1991) Adv. Neuroblastoma Res., 3, pp. 181-191
Biedler, J.L., Peterson, R.H.F., Molecular actions and targets for cancer chemotherapeutic agents (1981) Bristol-Myers Cancer Symposia, pp. 453-482. , A.C. Sartorelli, J.S. Lazo, & J.R. Bertino. New York: Academic Press
Biedler, J.L., Spengler, B.A., Cytogenetic manifestations of multidrug resistance (1996) Multidrug Resistance in Cancer Cells, pp. 61-78. , S. Gupta, & T. Tsruo. New York: Wiley
Bradley, G., Juranka, P.F., Ling, V., Mechanism of multidrug resistance (1988) Biochim. Biophys. Acta, 948, pp. 87-128
Chan, H.S.L., Haddad, G., Thorner, P.S., Deboer, D., Lin, Y.P., Ondrusek, N., Yeger, H., Ling, V., P-glycoprotein expression as a predictor of the outcome of therapy for neuroblastoma (1991) N. Engl. J. Med., 325, pp. 1608-1614
Dano, K., Cross-resistance between vinca-alkaloids and anthra cyclines in Ehrlich ascites tumor in vivo (1972) Cancer Chemother. Rep., 56, pp. 701-708
Dano, K., Active outward transport of daunomicin in resistant Ehrlich ascites tumor cells (1973) Biochim. Biophys. Acta, 323, pp. 466-483
Del Vecchio, S., Ciarmiello, A., Pace, L., Potena, M.I., Carriero, M.V., Mainolfi, C., Thomas, R., Salvatore, M., Fractional retention of technetium-99m-sestamibi as an index of P-glycoprotein expression in untreated breast cancer patients (1997) J. Nucl. Med., 38, pp. 1348-1351
Del Vecchio, S., Reynolds, J.C., Blasberg, R.G., Neumann, R.D., Carrasquillo, J.A., Hellstrom, I., Larson, S.M., Measurement of local Mr 97,000 and 250,000 protein antigen concentration in sections of human melanoma tumor using in vitro quantitative autoradiography (1988) Cancer Res, 48, pp. 5475-5481
Del Vecchio, S., Stoppelli, M.P., Carriero, M.V., Fonti, R., Massa, O., Li, P.J., Botti, G., Salvatore, M., Human urokinase receptor concentration in malignant and benign breast tumors by in vitro quantitative autoradiography: Comparison with urokinase levels (1993) Cancer Res, 53, pp. 3198-3206
Fojo, A.T., Ueda, K., Slamon, D.J., Poplack, D.G., Gottesman, M.M., Pastan, I., Expression of a multidrug-resistance gene in human tumors and tissues (1987) Proc. Natl. Acad. Sci. USA, 84, pp. 265-269
Fraker, P.J., Speck, J.C., Protein and cell membrane iodinations with a sparingly soluble chloramide 1,3,4,6-tetrachloro-3 a,6a-diphenylglycouril (1978) Biochem. Biophys. Res. Commun., 80, pp. 849-857
Georges, E., Tsuruo, T., Ling, V., Topology of P-glycoprtein as determined by epitope mapping of MRK16 monoclonal antibody (1993) J. Biol. Chem., 268, pp. 1792-1798
Gudkov, A.V., Multiple drug resistance in tumor cells: Manifestations, clinical basis, clinical aspects (1987) Mol. Gen. Microbiol. Virusol., 3, pp. 3-9
Hulme, E.C., (1992) Receptor-Ligand Interactions. a Practical Approach, , New York: Oxford University Press
Inaba, M., Fujikura, R., Sakurai, Y., Active efflux common to vincristine and daunorubicin in vincristine resistant P388 leukemia (1981) Biochem. Pharmacol., 30, pp. 1863-1865
Juliano, R.L., Ling, V., A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants (1976) Biochim. Biophys. Acta, 455, pp. 152-162
Kartner, N., Everdnen-Porelle, D., Bradley, G., Ling, V., Detection of P-glycoprotein in multidrug-resistant cell lines by monoclonal antibodies (1985) Nature, 316, pp. 820-823
Kartner, N., Shales, M., Riordan, J.R., Ling, V., Daunorubicin-resistant Chinese hamster ovary cells expressing multidrug-resistance and a cell surface P-glycoprotein (1983) Cancer Res, 43, pp. 4413-4419
Kobayashi, Y., Yamashiro, T., Nagatake, H., Yamamoto, Y., Watanabe, N., Tanaka, H., Shigenobu, K., Tsuruo, T., Expression and function of multidrug resistance P-glycoprotein in a cultured natural killer cell-rich population revealed by MRK16 monoclonal antibody and AHC-52 (1994) Biochem. Pharmacol., 48, pp. 1641-1646
Kohno, K., Molecular mechanism of the stress induction of MDR1 gene (1997) Nippon Rinsho, 55, pp. 1054-1058
Levchenko, A., Mehta, B.M., Spengler, B.A., Narkar, A.A., Fonti, R., Biedler, J.L., Tsuruo, T., Larson, S.M., Measurement of P-glycoprotein expression in multidrug-resistant human neuroblastoma cell lines using self-competitive binding assay (1996) Anal. Biochem., 236, pp. 338-343
Lindmo, T., Boven, E., Cutitta, F., Fedorko, J., Bunn, P.A., Determination of the immunoreactive fraction of radiolabeled monoclonal antibodies by linear extrapolation to binding at infinite antigen excess (1984) J. Immunol. Methods, 72, pp. 77-89
Ling, V., Thompson, L.H., Reduced permeability in CHO cells as a mechanism of resistance to colchicine (1974) J. Cell Physiol., 83, pp. 103-116
Mehta, B.M., Levchenko, A., Rosa, E., Kim, S.W., Winnick, S., Zhang, J.J., Kalaigian, H., Larson, S.M., Evaluation of carbon-14-colchicine biodistribution with whole body quantitative autoradiography in colchicine sensitive and resistant xenografts (1996) J. Nucl. Med., 37, pp. 312-314
Mehta, B., Rosa, E., Fissekis, J.D., Bading, J.R., Biedler, J.R., Larson, S.M., In vivo identification of tumor multidrug resistance with H3-colchicine (1992) J. Nucl. Med., 33, pp. 1373-1377
Merkel, D.E., Fuqua, S.A.W., Tandon, A.K., Hill, S.M., Buzdar, A.U., McGuire, W.L., Electrophoretic analysis of 248 clinical breast cancer specimens for P-glycoprotein overexpression or gene amplification (1989) J. Clin. Oncol., 7, pp. 1129-1136
Motulsky, H.J., Ransnas, L.A., Fitting curves to data using nonlinear regression: A practical and nonmathematical review (1987) FASEB J, 1, pp. 365-374
Ramu, A., Glaubiger, D., Magrath, I.T., Joshi, A., Plasma membrane lipid structural order in doxorubicin-sensitive resistant P388 cells (1983) Cancer Res, 43, pp. 5533-5537
Scott, A.M., Rosa, E., Mehta, B.M., Divgi, C.R., Finn, R.D., Biedler, J.L., Tsuruo, T., Larson, S.M., In vivo imaging and specific targeting of P-glycoprotein expression in multidrug resistant nude mice xenografts with 125I-MRK16 monoclonal antibody (1995) Nucl. Med. Biol., 22, pp. 497-504
Shen, D.W., Pastan, I., Gottesman, M.M., In situ hybridization analysis of acquisition and loss of human multidrug resistance gene (1988) Cancer Res, 48, pp. 4334-4339
Sirotnak, F.M., Yang, C.H., Mines, L.S., Oribe, E., Biedler, J.L., Markedly altered membrane transport and intracellular binding of vincristine in multidrug-resistant Chinese hamster cells selected for resistance to vinca alkaloids (1986) J. Cell Physiol., 126, pp. 266-274
Skovsgaard, T., Mechanism of cross-resistance between vincristine and daunorubicin in Erlich ascites tumor cells (1978) Cancer Res, 38, pp. 4722-4727
Sugawara, I., Kataoka, I., Morishita, Y., Hamada, H., Tsuruo, T., Itoyama, S., Mori, S., Tissue distribution of P-glycoprotein encoded by a multidrug-resistant gene as revealed by the monoclonal antibody MRK16 (1988) Cancer Res, 48, pp. 1926-1929
Tanaka, Y., Abe, Y., Tsugu, A., Takamiya, Y., Akatsuka, A., Tsuruo, T., Yamazaki, H., Nakamura, M., Ultrastructural localization of P-glycoprotein on capillary endothelial cells in human gliomas (1994) Virchows Arch, 425, pp. 133-138
Thiebaut, T., Tsuruo, T., Hamada, H., Gottesman, M.M., Pastan, I., Willingam, M.C., Cellular localization of the multidrug-resistant gene product P-glycoprotein in normal human tissues (1987) Proc. Natl. Acad. Sci. USA, 84, pp. 7735-7738
Tsuji, A., Terasaki, T., Takabatake, Y., Tenda, Y., Tamai, I., Yamashima, T., Moritani, S., Yamashita, J., P-glycoprotein as the drug efflux pump in primary cultured bovine brain capillary endothelial cells (1992) Life Sci, 51, pp. 1427-1437
Van Der Bliek, A.M., Borst, P., Multidrug resistance (1989) Adv. Cancer Res., 52, pp. 165-202
Verelle, P., Meissonmier, F., Fonck, Y., Clinical relevance of immunohistochemical detection of multidrug-resistance in breast carcinoma (1991) J. Natl. Cancer Inst., 83, pp. 111-116
Vollrath, V., Chianale, J., Gonzales, S., Duarte, I., Andrade, L., Ibanez, L., Multidrug resistance gene and P-glycoprotein expression in gastric adenocarcinoma and precursor lesions (1991) Virchows Archiv. B, Cell Pathol. Mol. Pathol., 60, pp. 133-138
Young, A.B., Frey, K.A., Agranoff, B.W., Receptor assay: In vitro and in vivo (1986) Positron Emission Tomography and Autoradiography: Principles and Applications for the Brain and Heart, pp. 73-111. , M. Phelps, J. Mazziotta, & H. Schelbert. New York: Raven Press
Aldrich, C. D., Pleiotropic phenothype of cultured murine cells resistant to maytansine, vincristine, colchicine and adriamycin (1979) J. Natl. Cancer Inst., 63, pp. 751-75
Beck, W. T., Grogan, T. M., Willman, C. L., Cordon-Cardo, C., Parham, D. M., Kuttesch, J. F., Andreeff, M., Weinstein, R., Methods to detect P-glycoprotein-associated multidrug resistance in patients' tumors: Consensus recommendations (1996) Cancer Res, 56, pp. 3010-3020
Biedler, J. L., Cassals, D., Chang, T. D., Meyers, M. B., Ross, R. A., Multidrug resistant human neuroblastoma cells are more differentiated than controls and retinoic acid further induces lineage-specific differentiation (1991) Adv. Neuroblastoma Res., 3, pp. 181-191
Biedler, J. L., Peterson, R. H. F., Molecular actions and targets for cancer chemotherapeutic agents (1981) Bristol-Myers Cancer Symposia, pp. 453-482. , A. C. Sartorelli, J. S. Lazo, & J. R. Bertino. New York: Academic Press
Biedler, J. L., Spengler, B. A., Cytogenetic manifestations of multidrug resistance (1996) Multidrug Resistance in Cancer Cells, pp. 61-78. , S. Gupta, & T. Tsruo. New York: Wiley
Chan, H. S. L., Haddad, G., Thorner, P. S., Deboer, D., Lin, Y. P., Ondrusek, N., Yeger, H., Ling, V., P-glycoprotein expression as a predictor of the outcome of therapy for neuroblastoma (1991) N. Engl. J. Med., 325, pp. 1608-1614
Fojo, A. T., Ueda, K., Slamon, D. J., Poplack, D. G., Gottesman, M. M., Pastan, I., Expression of a multidrug-resistance gene in human tumors and tissues (1987) Proc. Natl. Acad. Sci. USA, 84, pp. 265-269
Fraker, P. J., Speck, J. C., Protein and cell membrane iodinations with a sparingly soluble chloramide 1, 3, 4, 6-tetrachloro-3 a, 6a-diphenylglycouril (1978) Biochem. Biophys. Res. Commun., 80, pp. 849-857
Gudkov, A. V., Multiple drug resistance in tumor cells: Manifestations, clinical basis, clinical aspects (1987) Mol. Gen. Microbiol. Virusol., 3, pp. 3-9
Hulme, E. C., (1992) Receptor-Ligand Interactions. a Practical Approach, , New York: Oxford University Press
Juliano, R. L., Ling, V., A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants (1976) Biochim. Biophys. Acta, 455, pp. 152-162
Mehta, B. M., Levchenko, A., Rosa, E., Kim, S. W., Winnick, S., Zhang, J. J., Kalaigian, H., Larson, S. M., Evaluation of carbon-14-colchicine biodistribution with whole body quantitative autoradiography in colchicine sensitive and resistant xenografts (1996) J. Nucl. Med., 37, pp. 312-314
Merkel, D. E., Fuqua, S. A. W., Tandon, A. K., Hill, S. M., Buzdar, A. U., McGuire, W. L., Electrophoretic analysis of 248 clinical breast cancer specimens for P-glycoprotein overexpression or gene amplification (1989) J. Clin. Oncol., 7, pp. 1129-1136
Motulsky, H. J., Ransnas, L. A., Fitting curves to data using nonlinear regression: A practical and nonmathematical review (1987) FASEB J, 1, pp. 365-374
Scott, A. M., Rosa, E., Mehta, B. M., Divgi, C. R., Finn, R. D., Biedler, J. L., Tsuruo, T., Larson, S. M., In vivo imaging and specific targeting of P-glycoprotein expression in multidrug resistant nude mice xenografts with 125I-MRK16 monoclonal antibody (1995) Nucl. Med. Biol., 22, pp. 497-504
Shen, D. W., Pastan, I., Gottesman, M. M., In situ hybridization analysis of acquisition and loss of human multidrug resistance gene (1988) Cancer Res, 48, pp. 4334-4339
Sirotnak, F. M., Yang, C. H., Mines, L. S., Oribe, E., Biedler, J. L., Markedly altered membrane transport and intracellular binding of vincristine in multidrug-resistant Chinese hamster cells selected for resistance to vinca alkaloids (1986) J. Cell Physiol., 126, pp. 266-274
Van Der Bliek, A. M., Borst, P., Multidrug resistance (1989) Adv. Cancer Res., 52, pp. 165-202
Young, A. B., Frey, K. A., Agranoff, B. W., Receptor assay: In vitro and in vivo (1986) Positron Emission Tomography and Autoradiography: Principles and Applications for the Brain and Heart, pp. 73-111. , M. Phelps, J. Mazziotta, & H. Schelbert. New York: Raven Press
Nucl Med Biol (ISSN: 0969-8051, 0883-2897), 1999 Jan; 26(1): 35-41.
Export to Esporta in BibTeX Export to Esporta in EndNote
Paper type Tipo di articolo: Journal Article,
Impact factor: 1.623, 5-year impact factor Impact factor a 5 anni: 2.442
Url: http://www.scopus.com/inward/record.url?eid=2-s2.0-0032891335&partnerID=40&md5=4f03b29e8e055cd92d87b0175450d18b
Keywords Parole chiave: Mrk16, Multidrug Resistance, P-Glycoprotein, Quantitative Autoradiography, Self-Competitive Binding Assay, Iodine 125, Monoclonal Antibody Mrk 16, Animal Experiment, Article, Cancer Cell Culture, Cancer Transplantation, Human, Human Cell, Isotope Labeling, Mouse, Neuroblastoma, Nonhuman, Nude Mouse, Protein Determination, Protein Expression, Quantitative Assay, Radioassay, Tissue Distribution, Antibodies, Multiple, Iodine Radioisotopes, Inbred Balb C, Neoplasm Transplantation, Heterologous, Tumor Cells,
Affiliations Affiliazioni:
Department of Nuclear Medicine, Mem. Sloan-Kettering Cancer C., New York, NY, United States
Inst. of Molec. and Cell. Biosci., University of Tokyo, Tokyo, Japan
References Riferimenti:
Aldrich, C.D., Pleiotropic phenothype of cultured murine cells resistant to maytansine, vincristine, colchicine and adriamycin (1979) J. Natl. Cancer Inst., 63, pp. 751-75
Beck, W.T., Grogan, T.M., Willman, C.L., Cordon-Cardo, C., Parham, D.M., Kuttesch, J.F., Andreeff, M., Weinstein, R., Methods to detect P-glycoprotein-associated multidrug resistance in patients' tumors: Consensus recommendations (1996) Cancer Res, 56, pp. 3010-3020
Biedler, J.L., Cassals, D., Chang, T.D., Meyers, M.B., Ross, R.A., Multidrug resistant human neuroblastoma cells are more differentiated than controls and retinoic acid further induces lineage-specific differentiation (1991) Adv. Neuroblastoma Res., 3, pp. 181-191
Biedler, J.L., Peterson, R.H.F., Molecular actions and targets for cancer chemotherapeutic agents (1981) Bristol-Myers Cancer Symposia, pp. 453-482. , A.C. Sartorelli, J.S. Lazo, & J.R. Bertino. New York: Academic Press
Biedler, J.L., Spengler, B.A., Cytogenetic manifestations of multidrug resistance (1996) Multidrug Resistance in Cancer Cells, pp. 61-78. , S. Gupta, & T. Tsruo. New York: Wiley
Bradley, G., Juranka, P.F., Ling, V., Mechanism of multidrug resistance (1988) Biochim. Biophys. Acta, 948, pp. 87-128
Chan, H.S.L., Haddad, G., Thorner, P.S., Deboer, D., Lin, Y.P., Ondrusek, N., Yeger, H., Ling, V., P-glycoprotein expression as a predictor of the outcome of therapy for neuroblastoma (1991) N. Engl. J. Med., 325, pp. 1608-1614
Dano, K., Cross-resistance between vinca-alkaloids and anthra cyclines in Ehrlich ascites tumor in vivo (1972) Cancer Chemother. Rep., 56, pp. 701-708
Dano, K., Active outward transport of daunomicin in resistant Ehrlich ascites tumor cells (1973) Biochim. Biophys. Acta, 323, pp. 466-483
Del Vecchio, S., Ciarmiello, A., Pace, L., Potena, M.I., Carriero, M.V., Mainolfi, C., Thomas, R., Salvatore, M., Fractional retention of technetium-99m-sestamibi as an index of P-glycoprotein expression in untreated breast cancer patients (1997) J. Nucl. Med., 38, pp. 1348-1351
Del Vecchio, S., Reynolds, J.C., Blasberg, R.G., Neumann, R.D., Carrasquillo, J.A., Hellstrom, I., Larson, S.M., Measurement of local Mr 97,000 and 250,000 protein antigen concentration in sections of human melanoma tumor using in vitro quantitative autoradiography (1988) Cancer Res, 48, pp. 5475-5481
Del Vecchio, S., Stoppelli, M.P., Carriero, M.V., Fonti, R., Massa, O., Li, P.J., Botti, G., Salvatore, M., Human urokinase receptor concentration in malignant and benign breast tumors by in vitro quantitative autoradiography: Comparison with urokinase levels (1993) Cancer Res, 53, pp. 3198-3206
Fojo, A.T., Ueda, K., Slamon, D.J., Poplack, D.G., Gottesman, M.M., Pastan, I., Expression of a multidrug-resistance gene in human tumors and tissues (1987) Proc. Natl. Acad. Sci. USA, 84, pp. 265-269
Fraker, P.J., Speck, J.C., Protein and cell membrane iodinations with a sparingly soluble chloramide 1,3,4,6-tetrachloro-3 a,6a-diphenylglycouril (1978) Biochem. Biophys. Res. Commun., 80, pp. 849-857
Georges, E., Tsuruo, T., Ling, V., Topology of P-glycoprtein as determined by epitope mapping of MRK16 monoclonal antibody (1993) J. Biol. Chem., 268, pp. 1792-1798
Gudkov, A.V., Multiple drug resistance in tumor cells: Manifestations, clinical basis, clinical aspects (1987) Mol. Gen. Microbiol. Virusol., 3, pp. 3-9
Hulme, E.C., (1992) Receptor-Ligand Interactions. a Practical Approach, , New York: Oxford University Press
Inaba, M., Fujikura, R., Sakurai, Y., Active efflux common to vincristine and daunorubicin in vincristine resistant P388 leukemia (1981) Biochem. Pharmacol., 30, pp. 1863-1865
Juliano, R.L., Ling, V., A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants (1976) Biochim. Biophys. Acta, 455, pp. 152-162
Kartner, N., Everdnen-Porelle, D., Bradley, G., Ling, V., Detection of P-glycoprotein in multidrug-resistant cell lines by monoclonal antibodies (1985) Nature, 316, pp. 820-823
Kartner, N., Shales, M., Riordan, J.R., Ling, V., Daunorubicin-resistant Chinese hamster ovary cells expressing multidrug-resistance and a cell surface P-glycoprotein (1983) Cancer Res, 43, pp. 4413-4419
Kobayashi, Y., Yamashiro, T., Nagatake, H., Yamamoto, Y., Watanabe, N., Tanaka, H., Shigenobu, K., Tsuruo, T., Expression and function of multidrug resistance P-glycoprotein in a cultured natural killer cell-rich population revealed by MRK16 monoclonal antibody and AHC-52 (1994) Biochem. Pharmacol., 48, pp. 1641-1646
Kohno, K., Molecular mechanism of the stress induction of MDR1 gene (1997) Nippon Rinsho, 55, pp. 1054-1058
Levchenko, A., Mehta, B.M., Spengler, B.A., Narkar, A.A., Fonti, R., Biedler, J.L., Tsuruo, T., Larson, S.M., Measurement of P-glycoprotein expression in multidrug-resistant human neuroblastoma cell lines using self-competitive binding assay (1996) Anal. Biochem., 236, pp. 338-343
Lindmo, T., Boven, E., Cutitta, F., Fedorko, J., Bunn, P.A., Determination of the immunoreactive fraction of radiolabeled monoclonal antibodies by linear extrapolation to binding at infinite antigen excess (1984) J. Immunol. Methods, 72, pp. 77-89
Ling, V., Thompson, L.H., Reduced permeability in CHO cells as a mechanism of resistance to colchicine (1974) J. Cell Physiol., 83, pp. 103-116
Mehta, B.M., Levchenko, A., Rosa, E., Kim, S.W., Winnick, S., Zhang, J.J., Kalaigian, H., Larson, S.M., Evaluation of carbon-14-colchicine biodistribution with whole body quantitative autoradiography in colchicine sensitive and resistant xenografts (1996) J. Nucl. Med., 37, pp. 312-314
Mehta, B., Rosa, E., Fissekis, J.D., Bading, J.R., Biedler, J.R., Larson, S.M., In vivo identification of tumor multidrug resistance with H3-colchicine (1992) J. Nucl. Med., 33, pp. 1373-1377
Merkel, D.E., Fuqua, S.A.W., Tandon, A.K., Hill, S.M., Buzdar, A.U., McGuire, W.L., Electrophoretic analysis of 248 clinical breast cancer specimens for P-glycoprotein overexpression or gene amplification (1989) J. Clin. Oncol., 7, pp. 1129-1136
Motulsky, H.J., Ransnas, L.A., Fitting curves to data using nonlinear regression: A practical and nonmathematical review (1987) FASEB J, 1, pp. 365-374
Ramu, A., Glaubiger, D., Magrath, I.T., Joshi, A., Plasma membrane lipid structural order in doxorubicin-sensitive resistant P388 cells (1983) Cancer Res, 43, pp. 5533-5537
Scott, A.M., Rosa, E., Mehta, B.M., Divgi, C.R., Finn, R.D., Biedler, J.L., Tsuruo, T., Larson, S.M., In vivo imaging and specific targeting of P-glycoprotein expression in multidrug resistant nude mice xenografts with 125I-MRK16 monoclonal antibody (1995) Nucl. Med. Biol., 22, pp. 497-504
Shen, D.W., Pastan, I., Gottesman, M.M., In situ hybridization analysis of acquisition and loss of human multidrug resistance gene (1988) Cancer Res, 48, pp. 4334-4339
Sirotnak, F.M., Yang, C.H., Mines, L.S., Oribe, E., Biedler, J.L., Markedly altered membrane transport and intracellular binding of vincristine in multidrug-resistant Chinese hamster cells selected for resistance to vinca alkaloids (1986) J. Cell Physiol., 126, pp. 266-274
Skovsgaard, T., Mechanism of cross-resistance between vincristine and daunorubicin in Erlich ascites tumor cells (1978) Cancer Res, 38, pp. 4722-4727
Sugawara, I., Kataoka, I., Morishita, Y., Hamada, H., Tsuruo, T., Itoyama, S., Mori, S., Tissue distribution of P-glycoprotein encoded by a multidrug-resistant gene as revealed by the monoclonal antibody MRK16 (1988) Cancer Res, 48, pp. 1926-1929
Tanaka, Y., Abe, Y., Tsugu, A., Takamiya, Y., Akatsuka, A., Tsuruo, T., Yamazaki, H., Nakamura, M., Ultrastructural localization of P-glycoprotein on capillary endothelial cells in human gliomas (1994) Virchows Arch, 425, pp. 133-138
Thiebaut, T., Tsuruo, T., Hamada, H., Gottesman, M.M., Pastan, I., Willingam, M.C., Cellular localization of the multidrug-resistant gene product P-glycoprotein in normal human tissues (1987) Proc. Natl. Acad. Sci. USA, 84, pp. 7735-7738
Tsuji, A., Terasaki, T., Takabatake, Y., Tenda, Y., Tamai, I., Yamashima, T., Moritani, S., Yamashita, J., P-glycoprotein as the drug efflux pump in primary cultured bovine brain capillary endothelial cells (1992) Life Sci, 51, pp. 1427-1437
Van Der Bliek, A.M., Borst, P., Multidrug resistance (1989) Adv. Cancer Res., 52, pp. 165-202
Verelle, P., Meissonmier, F., Fonck, Y., Clinical relevance of immunohistochemical detection of multidrug-resistance in breast carcinoma (1991) J. Natl. Cancer Inst., 83, pp. 111-116
Vollrath, V., Chianale, J., Gonzales, S., Duarte, I., Andrade, L., Ibanez, L., Multidrug resistance gene and P-glycoprotein expression in gastric adenocarcinoma and precursor lesions (1991) Virchows Archiv. B, Cell Pathol. Mol. Pathol., 60, pp. 133-138
Young, A.B., Frey, K.A., Agranoff, B.W., Receptor assay: In vitro and in vivo (1986) Positron Emission Tomography and Autoradiography: Principles and Applications for the Brain and Heart, pp. 73-111. , M. Phelps, J. Mazziotta, & H. Schelbert. New York: Raven Press
Aldrich, C. D., Pleiotropic phenothype of cultured murine cells resistant to maytansine, vincristine, colchicine and adriamycin (1979) J. Natl. Cancer Inst., 63, pp. 751-75
Beck, W. T., Grogan, T. M., Willman, C. L., Cordon-Cardo, C., Parham, D. M., Kuttesch, J. F., Andreeff, M., Weinstein, R., Methods to detect P-glycoprotein-associated multidrug resistance in patients' tumors: Consensus recommendations (1996) Cancer Res, 56, pp. 3010-3020
Biedler, J. L., Cassals, D., Chang, T. D., Meyers, M. B., Ross, R. A., Multidrug resistant human neuroblastoma cells are more differentiated than controls and retinoic acid further induces lineage-specific differentiation (1991) Adv. Neuroblastoma Res., 3, pp. 181-191
Biedler, J. L., Peterson, R. H. F., Molecular actions and targets for cancer chemotherapeutic agents (1981) Bristol-Myers Cancer Symposia, pp. 453-482. , A. C. Sartorelli, J. S. Lazo, & J. R. Bertino. New York: Academic Press
Biedler, J. L., Spengler, B. A., Cytogenetic manifestations of multidrug resistance (1996) Multidrug Resistance in Cancer Cells, pp. 61-78. , S. Gupta, & T. Tsruo. New York: Wiley
Chan, H. S. L., Haddad, G., Thorner, P. S., Deboer, D., Lin, Y. P., Ondrusek, N., Yeger, H., Ling, V., P-glycoprotein expression as a predictor of the outcome of therapy for neuroblastoma (1991) N. Engl. J. Med., 325, pp. 1608-1614
Fojo, A. T., Ueda, K., Slamon, D. J., Poplack, D. G., Gottesman, M. M., Pastan, I., Expression of a multidrug-resistance gene in human tumors and tissues (1987) Proc. Natl. Acad. Sci. USA, 84, pp. 265-269
Fraker, P. J., Speck, J. C., Protein and cell membrane iodinations with a sparingly soluble chloramide 1, 3, 4, 6-tetrachloro-3 a, 6a-diphenylglycouril (1978) Biochem. Biophys. Res. Commun., 80, pp. 849-857
Gudkov, A. V., Multiple drug resistance in tumor cells: Manifestations, clinical basis, clinical aspects (1987) Mol. Gen. Microbiol. Virusol., 3, pp. 3-9
Hulme, E. C., (1992) Receptor-Ligand Interactions. a Practical Approach, , New York: Oxford University Press
Juliano, R. L., Ling, V., A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants (1976) Biochim. Biophys. Acta, 455, pp. 152-162
Mehta, B. M., Levchenko, A., Rosa, E., Kim, S. W., Winnick, S., Zhang, J. J., Kalaigian, H., Larson, S. M., Evaluation of carbon-14-colchicine biodistribution with whole body quantitative autoradiography in colchicine sensitive and resistant xenografts (1996) J. Nucl. Med., 37, pp. 312-314
Merkel, D. E., Fuqua, S. A. W., Tandon, A. K., Hill, S. M., Buzdar, A. U., McGuire, W. L., Electrophoretic analysis of 248 clinical breast cancer specimens for P-glycoprotein overexpression or gene amplification (1989) J. Clin. Oncol., 7, pp. 1129-1136
Motulsky, H. J., Ransnas, L. A., Fitting curves to data using nonlinear regression: A practical and nonmathematical review (1987) FASEB J, 1, pp. 365-374
Scott, A. M., Rosa, E., Mehta, B. M., Divgi, C. R., Finn, R. D., Biedler, J. L., Tsuruo, T., Larson, S. M., In vivo imaging and specific targeting of P-glycoprotein expression in multidrug resistant nude mice xenografts with 125I-MRK16 monoclonal antibody (1995) Nucl. Med. Biol., 22, pp. 497-504
Shen, D. W., Pastan, I., Gottesman, M. M., In situ hybridization analysis of acquisition and loss of human multidrug resistance gene (1988) Cancer Res, 48, pp. 4334-4339
Sirotnak, F. M., Yang, C. H., Mines, L. S., Oribe, E., Biedler, J. L., Markedly altered membrane transport and intracellular binding of vincristine in multidrug-resistant Chinese hamster cells selected for resistance to vinca alkaloids (1986) J. Cell Physiol., 126, pp. 266-274
Van Der Bliek, A. M., Borst, P., Multidrug resistance (1989) Adv. Cancer Res., 52, pp. 165-202
Young, A. B., Frey, K. A., Agranoff, B. W., Receptor assay: In vitro and in vivo (1986) Positron Emission Tomography and Autoradiography: Principles and Applications for the Brain and Heart, pp. 73-111. , M. Phelps, J. Mazziotta, & H. Schelbert. New York: Raven Press
Measurement of P-glycoprotein expression in human neuroblastoma xenografts using in vitro quantitative autoradiography
P-glycoprotein (P-gp) has a role in multidrug resistance (MDR) encountered in human cancers. In this study, we used the colchicine-resistant cell line BE(2)-C/CHCb(0.2), a strain of neuroblastoma cell line BE(2)-C, as a model to measure variations of P-gp expression in cells grown in vitro and in vivo. Cells were cultured in the medium supplemented with colchicine. At the beginning of the study the drug was withdrawn and, after 22 days, added back to the culture medium. Cells were harvested at various time points and xenografted in nude mice. P-gp COntent in cells was measured by self- competitive binding assay and in tumors, by quantitative autoradiography (QAR). Both assays were carried out using 125I-labeled monoclonal antibody MRK16, reactive with P-gp. Concentration of P-gp in cells varied from a maximum of 1,361 pmol/g in the presence of colchicine to a minimum of 374 pmol/g in the absence of colchicine in the culture medium. P-gp concentration in the tumors ranged from 929 to 188 pmol/g, which correlated with P-gp content in the cells at the time of their injection in the mice. QAR is an accurate and reliable method to quantify P-gp expression in tumors. Changes in colchicine concentration in the ambient medium of BE(2)-C/CHCb(0.2) cells growing in vitro resulted in a change in phenotype of P-gp expression, which was stable under conditions of in vivo growth over approximately 9 cell divisions in nude mice xenografts. Therefore, P-gp content in xenografts depends only on the level of resistance of the cells at the time of their injection in the mice.
P-glycoprotein (P-gp) has a role in multidrug resistance (MDR) encountered in human cancers. In this study, we used the colchicine-resistant cell line BE(2)-C/CHCb(0.2), a strain of neuroblastoma cell line BE(2)-C, as a model to measure variations of P-gp expression in cells grown in vitro and in vivo. Cells were cultured in the medium supplemented with colchicine. At the beginning of the study the drug was withdrawn and, after 22 days, added back to the culture medium. Cells were harvested at various time points and xenografted in nude mice. P-gp COntent in cells was measured by self- competitive binding assay and in tumors, by quantitative autoradiography (QAR). Both assays were carried out using 125I-labeled monoclonal antibody MRK16, reactive with P-gp. Concentration of P-gp in cells varied from a maximum of 1,361 pmol/g in the presence of colchicine to a minimum of 374 pmol/g in the absence of colchicine in the culture medium. P-gp concentration in the tumors ranged from 929 to 188 pmol/g, which correlated with P-gp content in the cells at the time of their injection in the mice. QAR is an accurate and reliable method to quantify P-gp expression in tumors. Changes in colchicine concentration in the ambient medium of BE(2)-C/CHCb(0.2) cells growing in vitro resulted in a change in phenotype of P-gp expression, which was stable under conditions of in vivo growth over approximately 9 cell divisions in nude mice xenografts. Therefore, P-gp content in xenografts depends only on the level of resistance of the cells at the time of their injection in the mice.
Measurement of P-glycoprotein expression in human neuroblastoma xenografts using in vitro quantitative autoradiography
No results. Nessun risultato. |
Measurement of P-glycoprotein expression in human neuroblastoma xenografts using in vitro quantitative autoradiography
Berisio R
* Editorial: Molecular determinants of bacterial diseases (322 visite)
Curr Med Chem (ISSN: 0929-8673, 1875-533x, 1875-533xelectronic), 2015; 22(14): 1640-1641.
Impact Factor: 3.455
Dettagli Esporta in BibTeX Esporta in EndNote
Bartolucci S, Contursi P, Fiorentino G, Limauro D, Pedone E
* Responding to toxic compounds: a genomic and functional overview of Archaea (601 visite)
Frontiers In Bioscience (ISSN: 1093-9946, 1093-4715), 2013 Jan 1; 18: 165-189.
Impact Factor: 4.249
Dettagli Esporta in BibTeX Esporta in EndNote
Zannetti A, Del Vecchio S, Iommelli F, Del Gatto A, De Luca S, Zaccaro L, Papaccioli A, Sommella J, Panico M, Speranza A, Grieco P, Novellino E, Saviano M, Pedone C, Salvatore M
* Imaging of αvβ3 expression by a bifunctional chimeric RGD peptide not cross-reacting with α vβ5 (799 visite)
Clin Cancer Res (ISSN: 1078-0432, 1078-0432linking, 1078-0432print), 2009 Sep 15; 15(16): 5224-5233.
Impact Factor: 6.747
Dettagli Esporta in BibTeX Esporta in EndNote
Di Fiore A, Fiorentino G, Vitale RM, Ronca R, Amodeo P, Pedone C, Bartolucci S, De Simone G
* Structural analysis of BldR from Sulfolobus solfataricus provides insights into the molecular basis of transcriptional activation in Archaea by MarR family proteins (449 visite)
J Mol Biol (ISSN: 1089-8638, 0022-2836, 1089-8638electronic), 2009 May 8; 388(3): 559-569.
Impact Factor: 3.871
Dettagli Esporta in BibTeX Esporta in EndNote
Del Vecchio S, Zannetti A, Fonti R, Iommelli F, Lettieri A, Salvatore M
* Molecular imaging of drug resistance in cancer (407 visite)
Minerva Biotecnol (ISSN: 1120-4826), 2009 Mar; 21(1): 31-36.
Impact Factor: 0.268
Dettagli Esporta in BibTeX Esporta in EndNote
Del Vecchio S, Zannetti A, Fonti R, Pace L, Salvatore M
* Nuclear imaging in cancer theranostics (570 visite)
Q J Nucl Med Mol Im (ISSN: 1824-4785, 1824-4478, 1824-4785linking), 2007 Jun; 51(2): 152-163.
Impact Factor: 1.724
Dettagli Esporta in BibTeX Esporta in EndNote
Pace L, Salvatore M, Del Vecchio S
* Use of Tc-99m-Sestamibi scintigraphy in multiple myeloma (224 visite)
J Nucl Med (ISSN: 1535-5667, 0161-5505, 1535-5667electronic), 2006 Mar; 47(3): 555-555.
Impact Factor: 4.986
Dettagli Esporta in BibTeX Esporta in EndNote
Del Vecchio S, Zannetti A, Salvatore B, Paone G, Fonti R, Salvatore M
* Functional imaging of multidrug resistance in breast cancer (381 visite)
Phys Med (ISSN: 1120-1797, 1120-1797linking), 2006; 21(SUPPL.1): 24-27.
Impact Factor: 0.313
Dettagli Esporta in BibTeX Esporta in EndNote
Pace L, Del Vecchio S, Salvatore M
* Technetium 99m sestamibi in multiple myeloma (248 visite)
Radiology (ISSN: 0033-8419, 1527-1315, 1527-1315electronic), 2005 Jan; 234(1): 312-313.
Impact Factor: 5.377
Dettagli Esporta in BibTeX Esporta in EndNote
Pace L, Del Vecchio S, Salvatore M, Walker RC, Angtuaco E, Sethi R, Fassas A, Barlogie B
* Technetium 99m sestamibi in multiple myeloma [3] (multiple letters) (315 visite)
Radiology (ISSN: 0033-8419, 1527-1315, 1527-1315electronic), 2005; 234(1): 312-313.
Impact Factor: 5.377
Dettagli Esporta in BibTeX Esporta in EndNote
Del Vecchio S, Salvatore M
* Tc-99m-MIBI in the evaluation of breast cancer biology (554 visite) (PDF 177 visite)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2004 Jun; 31(SUPPL.1): S88-S88.
Impact Factor: 3.935
Dettagli Esporta in BibTeX Esporta in EndNote
Fonti R, Del Vecchio S, Zannetti A, De Renzo A, Catalano L, Pace L, Rotoli B, Salvatore M
* Functional Imaging Of Multidrug Resistant Phenotype By 99mtc-Mibi Scan In Patients With Multiple Myeloma (434 visite)
Cancer Biotherapy And Radiopharmaceuticals (ISSN: 1084-9785, 1084-4978), 2004; 19(2): 165-170.
Impact Factor: 1.091
Dettagli Esporta in BibTeX Esporta in EndNote
Mansi R, Tesauro D, De Capua A, Fattorusso R, Carac C, Aloj L, Benedetti E, Morelli G
* Peptide-chelating agent conjugate for selective targeting of somatostatin receptor type 1: Synthesis and characterization (425 visite)
Biopolymers (ISSN: 0006-3525, 0006-6352, 0006-3525print), 2004; 76(6): 527-534.
Impact Factor: 2.863
Dettagli Esporta in BibTeX Esporta in EndNote
Del Vecchio S, Zannetti A, Aloj L, Salvatore M
* MIBI as prognostic factor in breast cancer (416 visite)
Q J Nucl Med (ISSN: 1124-3937, 1125-0135), 2003 Mar; 47(1): 46-50.
Impact Factor: 2.222
Dettagli Esporta in BibTeX Esporta in EndNote
Del Vecchio S, Zannetti A, Ciarmiello A, Aloj L, Caracò C, Fonti R, Botti G, D'Aiuto G, Salvatore M
* Dynamic coupling of Tc-99m-MIBI efflux and apoptotic pathway activation in untreated breast cancer patients (434 visite)
Eur J Nucl Med (ISSN: 1619-7070, 0340-6997, 1619-7089), 2002 Jun; 29(6): 809-814.
Impact Factor: 3.568
Dettagli Esporta in BibTeX Esporta in EndNote
Del Vecchio S, Ciarmiello A, Salvatore M
Scintigraphic detection of multidrug resistance in cancer (435 visite)
Cancer Biotherapy And Radiopharmaceuticals (ISSN: 1084-9785, 1084-4978), 2000 Sep; 15(4): 327-337.
Impact Factor: 0.989
Dettagli Esporta in BibTeX Esporta in EndNote
Del Vecchio S, Ciarmiello A, Salvatore M
Clinical imaging of multidrug resistance in cancer (345 visite)
Q J Nucl Med (ISSN: 1124-3937, 1125-0135), 1999 Jun; 43(2): 125-131.
Impact Factor: 2.125
Dettagli Esporta in BibTeX Esporta in EndNote
Renda A, Iovino F, Capasso L, Ricciardelli L, Tammaro V, Acampa W
Radioimmunoguided surgery in colorectal cancer: A 6-year experience with four different technical solutions (256 visite)
Semin Surg Oncol Wiley Liss Inc (ISSN: 8756-0437), 1998 Dec; 15(4): 226-230.
Impact Factor: 1.045
Dettagli Esporta in BibTeX Esporta in EndNote
Salvatore M, Del Vecchio S
Dynamic imaging: Scintimammography (367 visite)
Eur J Radiol Elsevier Sci Ireland Ltd (ISSN: 0720-048x), 1998 May; 27(SUPPL.2): S259-S259.
Impact Factor: 0.537
Dettagli Esporta in BibTeX Esporta in EndNote
Mansi L, Rambaldi PF, Cuccurullo V, Pecori B, Quarantelli M, Fallanca F, Del Vecchio E
Diagnostic and prognostic role of 99mTc-Tetrofosmin in breast cancer (264 visite)
Q J Nucl Med (ISSN: 1124-3937, 1125-0135), 1997 Sep; 41(3): 239-250.
Impact Factor: 2.125
Dettagli Esporta in BibTeX Esporta in EndNote
Del Vecchio S, Ciarmiello A, Pace L, Potena MI, Carriero MV, Mainolfi C, Thomas R, D'Aiuto G, Tsuruo T, Salvatore M
Fractional retention of technetium-99m-sestamibi as an index of P- glycoprotein expression in untreated breast cancer patients (665 visite)
J Nucl Med (ISSN: 0161-5505, 1535-5667, 1535-5667electronic), 1997 Sep; 38(9): 1348-1351.
Impact Factor: 3.491
Dettagli Esporta in BibTeX Esporta in EndNote
Carriero MV, Del Vecchio S, Franco P, Potena MI, Chiaradonna F, Botti G, Stoppelli MP, Salvatore M
Vitronectin binding to urokinase receptor in human breast cancer (403 visite)
Clin Cancer Res (ISSN: 1078-0432, 1078-0432linking, 1078-0432print), 1997 Sep; 3(8): 1299-1308.
Impact Factor: 3.419
Dettagli Esporta in BibTeX Esporta in EndNote
Levchenko A, Mehta B, Spengler BA, Narkar A, Fonti R, Biedler JL, Tsuruo T, Larson SM
Measurement of P-glycoprotein expression in multidrug-resistant human neuroblastoma cell lines using self-competitive binding assay (246 visite)
Anal Biochem (ISSN: 0003-2697, 1096-0309electronic, 0003-2697linking), 1996 May 1; 236(2): 338-343.
Impact Factor: 2.017
Dettagli Esporta in BibTeX Esporta in EndNote
Li PY, Del Vecchio S, Fonti R, Carriero MV, Potena MI, Botti G, Miotti S, Lastoria S, Menard S, Colnaghi MI, Salvatore M
Local concentration of folate binding protein GP38 in sections of human ovarian carcinoma by in vitro quantitative autoradiography (424 visite)
J Nucl Med (ISSN: 0161-5505, 1535-5667, 1535-5667electronic), 1996 Apr; 37(4-6): 665-672.
Impact Factor: 3.491
Dettagli Esporta in BibTeX Esporta in EndNote
Del Vecchio S, Ciarmiello A, Potena MI, Carriero MV, Mainolfi C, Botti G, Tsuruo T, Salvatore M
Quantitation of P-glycoprotein in sections of human breast carcinoma (274 visite)
J Nucl Med (ISSN: 0161-5505, 1535-5667, 1535-5667electronic), 1995; 36(5SUPPL.): N/D-N/D.
Impact Factor: 3.491
Dettagli Esporta in BibTeX Esporta in EndNote
Ciarmiello A, Del Vecchio S, Potena MI, Mainolfi C, Carriero MV, Tsuruo T, Marone A, Salvatore M
Tc-99m-SESTAMIBI efflux and P-glycoprotein expression in human breast carcinoma (234 visite)
J Nucl Med (ISSN: 0161-5505, 1535-5667, 1535-5667electronic), 1995; 36(5SUPPL.): N/D-N/D.
Impact Factor: 3.491
Dettagli Esporta in BibTeX Esporta in EndNote
Del Vecchio S, Stoppelli MP, Carriero MV, Fonti R, Massa O, Li PY, Botti G, Cerra M, D'Aiuto G, Esposito G, Salvatore M
IN-VITRO RECEPTOR IMAGING FOR CHARACTERIZATION OF HUMAN SOLID TUMORS (229 visite)
Nucl Med Biol (ISSN: 0883-2897, 0969-8051), 1994 Jul; 21(5): 771-774.
Impact Factor: 1.042
Dettagli Esporta in BibTeX Esporta in EndNote
Correale P, Caraglia M, Pepe S, Ricciardi B, Barile C, Montagnani S, Pacelli R, Bianco A, Tagliaferri P
PHORBOL 12-MYRISTATE 13-ACETATE (PMA) INDUCES NEUROENDOCRINE-LIKE DIFFERENTIATION AND REVERSES DOXORUBICIN-RESISTANCE OF HUMAN COLON-CARCINOMA CELLS IN-VITRO (286 visite)
Int J Oncol (ISSN: 1019-6439, 1791-2423electronic, 1019-6439linking), 1994 Feb; 4(2): 423-427.
Impact Factor: 1.181
Dettagli Esporta in BibTeX Esporta in EndNote
Del Vecchio S, Stoppelli MP, Carriere MV, Fonti R, Massa O, Li PY, Botti G, Cerra M, D'Aiuto G, Esposito G, Salvatore M
Human urokinase receptor concentration in malignant and benign breast tumors by in vitro quantitative autoradiography: Comparison with urokinase levels (257 visite)
Cancer Res (ISSN: 0008-5472, 1538-7445, 1538-7445electronic), 1993 Jul 1; 53(13): 3198-3206.
Impact Factor: 8.426
Dettagli Esporta in BibTeX Esporta in EndNote
Del Vecchio S, Reynolds JC, Blasberg RG, Neumann RD, Carrasquillo JA, Hellström I, Larson SM
Measurement of local Mr 97, 000 and 250, 000 protein antigen concentration in sections of human melanoma tumor using in vitro quantitative autoradiography (498 visite)
Cancer Res (ISSN: 0008-5472, 1538-7445, 1538-7445electronic), 1988; 48(19): 5475-5481.
Impact Factor: 8.426
Dettagli Esporta in BibTeX Esporta in EndNote
Trischitta V, Benzi L, Brunetti A, Cecchetti P, Marchetti P, Vigneri R, Navalesi R
Intracellular insulin processing is altered in monocytes from patients with type II diabetes mellitus (924 visite)
J Clin Endocrinol Metab (ISSN: 0021-972x), 1987 May; 64(5): 914-920.
Impact Factor: 4.575
Dettagli Esporta in BibTeX Esporta in EndNote
31 Records (26 escludendo Abstract e Conferenze).
Impact factor totale: 99.917 (83.477 escludendo Abstract e Conferenze).
Impact factor a 5 anni totale: 122.281 (98.653 escludendo Abstract e Conferenze).
Vai a fine pagina Versione per copia e incolla facile Esporta tutto in BibTeX Esporta tutto in EndNote
Berisio R
* Editorial: Molecular determinants of bacterial diseases (322 visite)
Curr Med Chem (ISSN: 0929-8673, 1875-533x, 1875-533xelectronic), 2015; 22(14): 1640-1641.
Impact Factor: 3.455
Dettagli Esporta in BibTeX Esporta in EndNote
Bartolucci S, Contursi P, Fiorentino G, Limauro D, Pedone E
* Responding to toxic compounds: a genomic and functional overview of Archaea (601 visite)
Frontiers In Bioscience (ISSN: 1093-9946, 1093-4715), 2013 Jan 1; 18: 165-189.
Impact Factor: 4.249
Dettagli Esporta in BibTeX Esporta in EndNote
Zannetti A, Del Vecchio S, Iommelli F, Del Gatto A, De Luca S, Zaccaro L, Papaccioli A, Sommella J, Panico M, Speranza A, Grieco P, Novellino E, Saviano M, Pedone C, Salvatore M
* Imaging of αvβ3 expression by a bifunctional chimeric RGD peptide not cross-reacting with α vβ5 (799 visite)
Clin Cancer Res (ISSN: 1078-0432, 1078-0432linking, 1078-0432print), 2009 Sep 15; 15(16): 5224-5233.
Impact Factor: 6.747
Dettagli Esporta in BibTeX Esporta in EndNote
Di Fiore A, Fiorentino G, Vitale RM, Ronca R, Amodeo P, Pedone C, Bartolucci S, De Simone G
* Structural analysis of BldR from Sulfolobus solfataricus provides insights into the molecular basis of transcriptional activation in Archaea by MarR family proteins (449 visite)
J Mol Biol (ISSN: 1089-8638, 0022-2836, 1089-8638electronic), 2009 May 8; 388(3): 559-569.
Impact Factor: 3.871
Dettagli Esporta in BibTeX Esporta in EndNote
Del Vecchio S, Zannetti A, Fonti R, Iommelli F, Lettieri A, Salvatore M
* Molecular imaging of drug resistance in cancer (407 visite)
Minerva Biotecnol (ISSN: 1120-4826), 2009 Mar; 21(1): 31-36.
Impact Factor: 0.268
Dettagli Esporta in BibTeX Esporta in EndNote
Del Vecchio S, Zannetti A, Fonti R, Pace L, Salvatore M
* Nuclear imaging in cancer theranostics (570 visite)
Q J Nucl Med Mol Im (ISSN: 1824-4785, 1824-4478, 1824-4785linking), 2007 Jun; 51(2): 152-163.
Impact Factor: 1.724
Dettagli Esporta in BibTeX Esporta in EndNote
Pace L, Salvatore M, Del Vecchio S
* Use of Tc-99m-Sestamibi scintigraphy in multiple myeloma (224 visite)
J Nucl Med (ISSN: 1535-5667, 0161-5505, 1535-5667electronic), 2006 Mar; 47(3): 555-555.
Impact Factor: 4.986
Dettagli Esporta in BibTeX Esporta in EndNote
Del Vecchio S, Zannetti A, Salvatore B, Paone G, Fonti R, Salvatore M
* Functional imaging of multidrug resistance in breast cancer (381 visite)
Phys Med (ISSN: 1120-1797, 1120-1797linking), 2006; 21(SUPPL.1): 24-27.
Impact Factor: 0.313
Dettagli Esporta in BibTeX Esporta in EndNote
Pace L, Del Vecchio S, Salvatore M
* Technetium 99m sestamibi in multiple myeloma (248 visite)
Radiology (ISSN: 0033-8419, 1527-1315, 1527-1315electronic), 2005 Jan; 234(1): 312-313.
Impact Factor: 5.377
Dettagli Esporta in BibTeX Esporta in EndNote
Pace L, Del Vecchio S, Salvatore M, Walker RC, Angtuaco E, Sethi R, Fassas A, Barlogie B
* Technetium 99m sestamibi in multiple myeloma [3] (multiple letters) (315 visite)
Radiology (ISSN: 0033-8419, 1527-1315, 1527-1315electronic), 2005; 234(1): 312-313.
Impact Factor: 5.377
Dettagli Esporta in BibTeX Esporta in EndNote
Del Vecchio S, Salvatore M
* Tc-99m-MIBI in the evaluation of breast cancer biology (554 visite) (PDF 177 visite)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2004 Jun; 31(SUPPL.1): S88-S88.
Impact Factor: 3.935
Dettagli Esporta in BibTeX Esporta in EndNote
Fonti R, Del Vecchio S, Zannetti A, De Renzo A, Catalano L, Pace L, Rotoli B, Salvatore M
* Functional Imaging Of Multidrug Resistant Phenotype By 99mtc-Mibi Scan In Patients With Multiple Myeloma (434 visite)
Cancer Biotherapy And Radiopharmaceuticals (ISSN: 1084-9785, 1084-4978), 2004; 19(2): 165-170.
Impact Factor: 1.091
Dettagli Esporta in BibTeX Esporta in EndNote
Mansi R, Tesauro D, De Capua A, Fattorusso R, Carac C, Aloj L, Benedetti E, Morelli G
* Peptide-chelating agent conjugate for selective targeting of somatostatin receptor type 1: Synthesis and characterization (425 visite)
Biopolymers (ISSN: 0006-3525, 0006-6352, 0006-3525print), 2004; 76(6): 527-534.
Impact Factor: 2.863
Dettagli Esporta in BibTeX Esporta in EndNote
Del Vecchio S, Zannetti A, Aloj L, Salvatore M
* MIBI as prognostic factor in breast cancer (416 visite)
Q J Nucl Med (ISSN: 1124-3937, 1125-0135), 2003 Mar; 47(1): 46-50.
Impact Factor: 2.222
Dettagli Esporta in BibTeX Esporta in EndNote
Del Vecchio S, Zannetti A, Ciarmiello A, Aloj L, Caracò C, Fonti R, Botti G, D'Aiuto G, Salvatore M
* Dynamic coupling of Tc-99m-MIBI efflux and apoptotic pathway activation in untreated breast cancer patients (434 visite)
Eur J Nucl Med (ISSN: 1619-7070, 0340-6997, 1619-7089), 2002 Jun; 29(6): 809-814.
Impact Factor: 3.568
Dettagli Esporta in BibTeX Esporta in EndNote
Del Vecchio S, Ciarmiello A, Salvatore M
Scintigraphic detection of multidrug resistance in cancer (435 visite)
Cancer Biotherapy And Radiopharmaceuticals (ISSN: 1084-9785, 1084-4978), 2000 Sep; 15(4): 327-337.
Impact Factor: 0.989
Dettagli Esporta in BibTeX Esporta in EndNote
Del Vecchio S, Ciarmiello A, Salvatore M
Clinical imaging of multidrug resistance in cancer (345 visite)
Q J Nucl Med (ISSN: 1124-3937, 1125-0135), 1999 Jun; 43(2): 125-131.
Impact Factor: 2.125
Dettagli Esporta in BibTeX Esporta in EndNote
Renda A, Iovino F, Capasso L, Ricciardelli L, Tammaro V, Acampa W
Radioimmunoguided surgery in colorectal cancer: A 6-year experience with four different technical solutions (256 visite)
Semin Surg Oncol Wiley Liss Inc (ISSN: 8756-0437), 1998 Dec; 15(4): 226-230.
Impact Factor: 1.045
Dettagli Esporta in BibTeX Esporta in EndNote
Salvatore M, Del Vecchio S
Dynamic imaging: Scintimammography (367 visite)
Eur J Radiol Elsevier Sci Ireland Ltd (ISSN: 0720-048x), 1998 May; 27(SUPPL.2): S259-S259.
Impact Factor: 0.537
Dettagli Esporta in BibTeX Esporta in EndNote
Mansi L, Rambaldi PF, Cuccurullo V, Pecori B, Quarantelli M, Fallanca F, Del Vecchio E
Diagnostic and prognostic role of 99mTc-Tetrofosmin in breast cancer (264 visite)
Q J Nucl Med (ISSN: 1124-3937, 1125-0135), 1997 Sep; 41(3): 239-250.
Impact Factor: 2.125
Dettagli Esporta in BibTeX Esporta in EndNote
Del Vecchio S, Ciarmiello A, Pace L, Potena MI, Carriero MV, Mainolfi C, Thomas R, D'Aiuto G, Tsuruo T, Salvatore M
Fractional retention of technetium-99m-sestamibi as an index of P- glycoprotein expression in untreated breast cancer patients (665 visite)
J Nucl Med (ISSN: 0161-5505, 1535-5667, 1535-5667electronic), 1997 Sep; 38(9): 1348-1351.
Impact Factor: 3.491
Dettagli Esporta in BibTeX Esporta in EndNote
Carriero MV, Del Vecchio S, Franco P, Potena MI, Chiaradonna F, Botti G, Stoppelli MP, Salvatore M
Vitronectin binding to urokinase receptor in human breast cancer (403 visite)
Clin Cancer Res (ISSN: 1078-0432, 1078-0432linking, 1078-0432print), 1997 Sep; 3(8): 1299-1308.
Impact Factor: 3.419
Dettagli Esporta in BibTeX Esporta in EndNote
Levchenko A, Mehta B, Spengler BA, Narkar A, Fonti R, Biedler JL, Tsuruo T, Larson SM
Measurement of P-glycoprotein expression in multidrug-resistant human neuroblastoma cell lines using self-competitive binding assay (246 visite)
Anal Biochem (ISSN: 0003-2697, 1096-0309electronic, 0003-2697linking), 1996 May 1; 236(2): 338-343.
Impact Factor: 2.017
Dettagli Esporta in BibTeX Esporta in EndNote
Li PY, Del Vecchio S, Fonti R, Carriero MV, Potena MI, Botti G, Miotti S, Lastoria S, Menard S, Colnaghi MI, Salvatore M
Local concentration of folate binding protein GP38 in sections of human ovarian carcinoma by in vitro quantitative autoradiography (424 visite)
J Nucl Med (ISSN: 0161-5505, 1535-5667, 1535-5667electronic), 1996 Apr; 37(4-6): 665-672.
Impact Factor: 3.491
Dettagli Esporta in BibTeX Esporta in EndNote
Del Vecchio S, Ciarmiello A, Potena MI, Carriero MV, Mainolfi C, Botti G, Tsuruo T, Salvatore M
Quantitation of P-glycoprotein in sections of human breast carcinoma (274 visite)
J Nucl Med (ISSN: 0161-5505, 1535-5667, 1535-5667electronic), 1995; 36(5SUPPL.): N/D-N/D.
Impact Factor: 3.491
Dettagli Esporta in BibTeX Esporta in EndNote
Ciarmiello A, Del Vecchio S, Potena MI, Mainolfi C, Carriero MV, Tsuruo T, Marone A, Salvatore M
Tc-99m-SESTAMIBI efflux and P-glycoprotein expression in human breast carcinoma (234 visite)
J Nucl Med (ISSN: 0161-5505, 1535-5667, 1535-5667electronic), 1995; 36(5SUPPL.): N/D-N/D.
Impact Factor: 3.491
Dettagli Esporta in BibTeX Esporta in EndNote
Del Vecchio S, Stoppelli MP, Carriero MV, Fonti R, Massa O, Li PY, Botti G, Cerra M, D'Aiuto G, Esposito G, Salvatore M
IN-VITRO RECEPTOR IMAGING FOR CHARACTERIZATION OF HUMAN SOLID TUMORS (229 visite)
Nucl Med Biol (ISSN: 0883-2897, 0969-8051), 1994 Jul; 21(5): 771-774.
Impact Factor: 1.042
Dettagli Esporta in BibTeX Esporta in EndNote
Correale P, Caraglia M, Pepe S, Ricciardi B, Barile C, Montagnani S, Pacelli R, Bianco A, Tagliaferri P
PHORBOL 12-MYRISTATE 13-ACETATE (PMA) INDUCES NEUROENDOCRINE-LIKE DIFFERENTIATION AND REVERSES DOXORUBICIN-RESISTANCE OF HUMAN COLON-CARCINOMA CELLS IN-VITRO (286 visite)
Int J Oncol (ISSN: 1019-6439, 1791-2423electronic, 1019-6439linking), 1994 Feb; 4(2): 423-427.
Impact Factor: 1.181
Dettagli Esporta in BibTeX Esporta in EndNote
Del Vecchio S, Stoppelli MP, Carriere MV, Fonti R, Massa O, Li PY, Botti G, Cerra M, D'Aiuto G, Esposito G, Salvatore M
Human urokinase receptor concentration in malignant and benign breast tumors by in vitro quantitative autoradiography: Comparison with urokinase levels (257 visite)
Cancer Res (ISSN: 0008-5472, 1538-7445, 1538-7445electronic), 1993 Jul 1; 53(13): 3198-3206.
Impact Factor: 8.426
Dettagli Esporta in BibTeX Esporta in EndNote
Del Vecchio S, Reynolds JC, Blasberg RG, Neumann RD, Carrasquillo JA, Hellström I, Larson SM
Measurement of local Mr 97, 000 and 250, 000 protein antigen concentration in sections of human melanoma tumor using in vitro quantitative autoradiography (498 visite)
Cancer Res (ISSN: 0008-5472, 1538-7445, 1538-7445electronic), 1988; 48(19): 5475-5481.
Impact Factor: 8.426
Dettagli Esporta in BibTeX Esporta in EndNote
Trischitta V, Benzi L, Brunetti A, Cecchetti P, Marchetti P, Vigneri R, Navalesi R
Intracellular insulin processing is altered in monocytes from patients with type II diabetes mellitus (924 visite)
J Clin Endocrinol Metab (ISSN: 0021-972x), 1987 May; 64(5): 914-920.
Impact Factor: 4.575
Dettagli Esporta in BibTeX Esporta in EndNote
31 Records (26 escludendo Abstract e Conferenze).
Impact factor totale: 99.917 (83.477 escludendo Abstract e Conferenze).
Impact factor a 5 anni totale: 122.281 (98.653 escludendo Abstract e Conferenze).
Last modified by Ultima modifica di Rosa Fonti on in data Sunday 12 July 2020, 13:15:13
246 views visite. Last view on Ultima visita in data Thursday 17 June 2021, 14:41:20
ibb.cnr.it